Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis

Critical Care Medicine

Volumn 30, Issue 7, 2002, Pages 1478-1482

  Joukhadar, Christian ^a   Klein, Nikolas ^a   Mayer, Bernhard X ^a   Kreischitz, Nicole ^a   Delle Karth, Georg ^a   Palkovits, Peter ^a   Heinz, Gottfried ^a   Müller, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cefpirome; Human; In vivo; Penetration; Sepsis; Target site

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFPIROME;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG PENETRATION; DRUG TISSUE LEVEL; EXPERIENCE; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEPSIS;

EID: 0036313816     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200207000-00013     Document Type: Article

References (19)

1. Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporins
2. Efficacy of cefpirome in the treatment of septicaemia
3. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock
4. Surgery and intensive care procedures affect the target site distribution of piperacillin
5. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans
6. A problem in the interpretation of beta-lactam antibiotic levels in tissues
7. The ACCP-SCCM consensus conference on sepsis and organ failure
8. A microdialysis method allowing characterization of intercellular water space in humans
9. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans
10. Micellar electrokinetic chromatography for the analysis of cefpirome in microdialysis and plasma samples obtained in vivo from human volunteers
11. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia
12. Microdialysis, a novel tool for the measurement of antibiotics in interstitium of humans
13. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome: Focus on antibacterial agents
14. Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin
15. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
16. The pharmacodynamics of β-lactams
17. Low cefpirome levels during twice daily dosing in critically ill septic patients: Pharmacokinetic modelling calls for more frequent dosing
18. Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome
19. Pharmacodynamics, a tool for a better use of antibiotics